Avant Diagnostics, Inc Contracts & Agreements
72 Contracts & Agreements
- Business Finance (49 contracts)
- Business Operations (11)
- Human Resources (3)
- Real Estate (1)
- Uncategorized (8)
- Form of Subscription Agreement for the Series D Preferred Stock Financing (Filed With SEC on March 26, 2019)
- Form of Subscription Agreement for the Series C Financing (Filed With SEC on August 28, 2018)
- Consulting Agreement, dated May 25, 2018, by and between the Company and AVDX Investor Group LLC (Filed With SEC on June 13, 2018)
- Form of Promissory Note issued to 2016 Investors, dated May 25, 2018 (Filed With SEC on May 25, 2018)
- Form of Convertible Promissory Note issued to Coastal Investment Partners, LLC, dated May 25, 2018 (Filed With SEC on May 25, 2018)
- Form of Promissory Note issued to Black Mountain Equity Partners LLC, dated May 25, 2018 (Filed With SEC on May 25, 2018)
- Form of Subscription Agreement for the May 2018 Financing (Filed With SEC on May 25, 2018)
- Form of Exchange Agreement by and between the Company and the 2017 Investors and the 2016 Investors (Filed With SEC on May 25, 2018)
- Form of Termination Agreement, dated May 25, 2018, by and between the Company and the 2017 Investors (Filed With SEC on May 25, 2018)
- Exchange Agreement, dated May 25, 2018, by and between the Company and Coastal Investment Partners, LLC (Filed With SEC on May 25, 2018)
- Termination Agreement, dated May 25, 2018, by and between the Company and Coastal Investment Partners, LLC (Filed With SEC on May 25, 2018)
- Exchange Agreement, dated May 25, 2018, by and between the Company and Black Mountain Equity Partners, LLC (Filed With SEC on May 25, 2018)
- Employment Agreement, dated May 25, 2018, by and between the Company and Dr. Mick Ruxin, M.D (Filed With SEC on May 25, 2018)
- Employment Agreement, dated May 25, 2018, by and between the Company and Jeff Busch (Filed With SEC on May 25, 2018)
- Asset Purchase Agreement, dated March 30, 2018, by and between Avant Diagnostics, Inc. and Amarantus Bioscience Holdings, Inc (Filed With SEC on April 6, 2018)
- Settlement Agreement, dated December 15, 2017, by and between Avant Diagnostics, Inc. and Philippe Goix (Filed With SEC on December 18, 2017)
- Form of Senior Secured Promissory Note related to the June 2017 and August 2017 Financing with the June 2017 Investor (Filed With SEC on September 26, 2017)
- Form of Warrant related to the related to the June 2017 and August 2017 Financing with the June 2017 Investor (Filed With SEC on September 26, 2017)
- Form of Right related to the related to the June 2017 and August 2017 Financing with the June 2017 Investor (Filed With SEC on September 26, 2017)
- Coastal51 Note, dated November 15, 2016 (Filed With SEC on September 26, 2017)
- Senior Secured Promissory Note, dated July 14, 2017 (Filed With SEC on September 26, 2017)
- Form of Senior Secured Promissory Note, dated July 28, 2017 (Filed With SEC on September 26, 2017)
- Senior Secured Promissory Note, dated August 8, 2017 issued to the August 2017 Investor (Filed With SEC on September 26, 2017)
- Warrant, dated August 8, 2017, issued to the August 2017 Investor (Filed With SEC on September 26, 2017)
- Purchase Right, dated August 8, 2017, issued to the August 2017 Investor (Filed With SEC on September 26, 2017)
- Senior Secured Promissory Note, dated September 5, 2017 issued to the September 2017 Investor (Filed With SEC on September 26, 2017)
- Warrant, dated September 5, 2017, issued to the September 2017 Investor (Filed With SEC on September 26, 2017)
- Purchase Right, dated September 5, 2017, issued to the September 2017 Investor (Filed With SEC on September 26, 2017)
- Form of Pledge Agreement by and between Avant Diagnostics, Inc. and the June 2017 Investor related to the June 2017 and August 2017 Financing (Filed With SEC on September 26, 2017)
- Satisfaction of Note, dated July 6, 2017, by and between Avant Diagnostics, Inc. and Black Mountain Equity Partners LLP (Filed With SEC on September 26, 2017)
- Exchange Agreement, dated July 14, 2017, by and between Avant Diagnostics, Inc. and Coastal Investment Partners LLP (Filed With SEC on September 26, 2017)
- Pledge Agreement, dated July 14, 2017, by and between Avant Diagnostics, Inc. and Coastal Investment Partners LLP (Filed With SEC on September 26, 2017)
- Binding Letter of Intent, dated July 14, 2017, by and between Avant Diagnostics, Inc. and Coastal Investment Partners LLP (Filed With SEC on September 26, 2017)
- Form of Exchange Agreement, dated July 28, 2017 (Filed With SEC on September 26, 2017)
- Form of Binding Letter of Intent, dated July 28, 2017 (Filed With SEC on September 26, 2017)
- Securities Purchase Agreement, dated August 8, 2017, by and between Avant Diagnostics, Inc. and the August 2017 Investor (Filed With SEC on September 26, 2017)
- Pledge Agreement dated August 8, 2017, by and between Avant Diagnostics, Inc. and the August 2017 Investor (Filed With SEC on September 26, 2017)
- Binding Letter of Intent with June 2017 Investor and August 2017 Investor, dated August 25, 2017 (Filed With SEC on September 26, 2017)
- Securities Purchase Agreement, dated September 5, 2017, by and between Avant Diagnostics, Inc. and the September 2017 Investor (Filed With SEC on September 26, 2017)
- Pledge Agreement dated September 5, 2017, by and between Avant Diagnostics, Inc. and the September 2017 Investor (Filed With SEC on September 26, 2017)
- Offer Letter, dated June 19, 2017, by and between Avant Diagnostics, Inc. and Philippe Goix (Filed With SEC on September 26, 2017)
- Settlement Agreement, dated June 2, 2017, by and between Avant Diagnostics, Inc. and Gregg Linn (Filed With SEC on September 26, 2017)
- Restricted Stock Grant Agreement, dated June 2, 2017, by and between Avant Diagnostics, Inc. and Gregg Linn (Filed With SEC on September 26, 2017)
- Second Amended and Restated Settlement Agreement, dated September 18, 2017, by and between the parties to the MemoryDx Litigation (Filed With SEC on September 26, 2017)
- Confidential Settlement Agreement, dated June 8, 2017, by and between the parties to the THI Litigation (Filed With SEC on September 26, 2017)
- Form of Promissory Note related to the October 2016 Financing (Filed With SEC on June 21, 2017)
- Form of Promissory Note related to the November 2016 Financing (Filed With SEC on June 21, 2017)
- Promissory Note, dated November 28, 2016, issued by Prism Health Dx, Inc. to Avant Diagnostics, Inc (Filed With SEC on June 21, 2017)
- Form of Senior Secured Promissory Note related to the June 2017 Financing (Filed With SEC on June 21, 2017)
- Form of Warrant related to the June 2017 Financing (Filed With SEC on June 21, 2017)
- Form of Right related to the June 2017 Financing (Filed With SEC on June 21, 2017)
- Binding Letter of Intent, dated November 28, 2016, by and between Avant Diagnostics, Inc. and Prism Health Dx, Inc (Filed With SEC on June 21, 2017)
- Exchange Agreement, dated January 27, 2017, by and between Avant Diagnostics and Gregg Linn (Filed With SEC on June 21, 2017)
- Securities Purchase Agreement, dated June 19, 2017 by and between Avant Diagnostics, Inc. and the June 2017 Investor (Filed With SEC on June 21, 2017)
- Pledge Agreement, dated June 19, 2017 by and between Avant Diagnostics, Inc. and the June 2017 Investor (Filed With SEC on June 21, 2017)
- CONVERTIBLE PROMISSORY NOTE DUE JANUARY 5, 2017 (Filed With SEC on July 11, 2016)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on July 11, 2016)
- SHARE EXCHANGE AGREEMENT (Filed With SEC on May 17, 2016)
- ASSET PURCHASE AGREEMENT BETWEEN THERANOSTICS HEALTH, INC. (as Seller) AND AVANT DIAGNOSTICS, INC. (as Buyer) May 11, 2016 (Filed With SEC on May 17, 2016)
- 12% CONVERTIBLE NOTE DUE MAY 11, 2017 (Filed With SEC on May 17, 2016)
- ASSIGNMENT AND FIRST AMENDMENT OF LEASE (Filed With SEC on May 17, 2016)
- 12% CONVERTIBLE NOTE DUE MARCH ___, 2017 (Filed With SEC on March 11, 2016)
- CONVERTIBLE PROMISSORY NOTE (Filed With SEC on January 12, 2016)
- ASSET PURCHASE AND SALE AGREEMENT (Filed With SEC on March 18, 2013)
- SECOND AMENDMENTTO OPERATING AGREEMENT (Filed With SEC on March 18, 2013)
- AMENDMENTTO OPERATING AGREEMENT (Filed With SEC on March 18, 2013)
- FIRST AMENDMENTTO OPERATING AGREEMENT (Filed With SEC on April 12, 2012)
- OPERATING AGREEMENT (Filed With SEC on September 19, 2011)
- OPERATING AGREEMENT (Filed With SEC on September 19, 2011)
- THIRD AMENDMENT TO OPTION AGREEMENT (Filed With SEC on June 20, 2011)
- SECONDAMENDMENT TO OPTIONAGREEMENT (Filed With SEC on February 15, 2011)
- FIRSTAMENDMENT TO OPTIONAGREEMENT (Filed With SEC on October 26, 2010)
